Fritextsökning
Innehållstyper
-
Will the industry follow the economic revival?
Welcome to the eleventh Biotech Forum + Scanlab Fair!
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
Ny modell ska identifiera rätt dos litium vid bipolär sjukdom
Ny forskning vid Karolinska institutet kan bidra till att lösa ett stort problem inom behandling av bipolär sjukdom: att hitta rätt dos litium för varje patient.
-
Vaccin mot borrelia kan bli verklighet
Franska Valneva, med tillverkning i Sverige, och amerikanska Pfizer inleder en fas III-studie med ett vaccin mot borrelia. Studien startar redan i år.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Changeable proteins cause nerve disease
An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all...
-
Gabor Fischer, Distribution Sales Manager Europe, Ismatec
Why are you going to Scanlab+Biotech Forum?
-
Per Norstedt, Regional Manager, AH Diagnostics
Why are you going to Scanlab+Biotech Forum?
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Dako appoints new CEO
The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Cancerdödande protein förstärks – med hjälp av spindeltråd
Länge har stora förhoppningar knutits till proteinet p53 som behandling mot cancer, men problemet är att kroppens celler tillverkar det i för liten mängd och at...
-
Einar Pontén, Managing Director, Merck Sequant
Why are you going to Scanlab+Biotech Forum?
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Nya datum för spännande event
The Future of Swedish & Danish Life Science och New Updates in Drug Formulation & Bioavailability flyttas fram till september.
-
New nanotech professor to DTU
The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Biovitrum sells UK part
Biovitrum will soon spin-out a British subsidary
-
Långsiktig effekt av hormonbehandling vid bröstcancer utredd
Hormonbehandling har en skyddande effekt mot spridd cancer vid både så kallad Luminal A och Luminal B bröstcancersubtyp. Det visar ny forskning från Karolinska institutet.
-
Virusforskare får Scilifelabpris
Forskningsinstitutet delar i samarbete med tidskriften Science ut pris till unga forskare.
-
A+Science söker vd
Göran Wessman lämnar sitt uppdrag. Bolagets operativa chef kliver in som tillförordnad vd medan rekrytering pågår.
-
Biogaia's advance goes on
In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.